Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry

BACKGROUND: Treatment of systemic onset juvenile idiopathic arthritis JIA (sJIA), although dramatically improved, remains a challenge. Experience from clinical practice will be presented using data from the German Biologics register (BiKeR) for evaluation of efficacy and safety of treatment with eta...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Arthritis Res Ther
मुख्य लेखकों: Horneff, Gerd, Schulz, Anna Carina, Klotsche, Jens, Hospach, Anton, Minden, Kirsten, Foeldvari, Ivan, Trauzeddel, Ralf, Ganser, Gerd, Weller-Heinemann, Frank, Haas, Johannes Perter
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2017
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5700562/
https://ncbi.nlm.nih.gov/pubmed/29166924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-017-1462-2
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन